Introduction: Who Should Undergo Diagnostics and When

If you are experiencing ongoing tiredness that does not go away, feeling unusually weak, or finding yourself short of breath during normal activities, it may be time to consider getting tested for anaemia. These symptoms develop because your blood is not carrying enough oxygen to your body’s tissues and organs. Sometimes anaemia develops so gradually that you might not notice the symptoms until they become more pronounced.^[1]

Women who are menstruating or pregnant, young children, and people with chronic medical conditions should pay special attention to symptoms of anaemia. Women who experience heavy periods may lose significant amounts of blood each month, which can deplete iron stores over time. During pregnancy, the body’s demand for iron increases substantially to support both the mother and the developing baby. People with conditions like kidney disease, cancer, inflammatory bowel disease, or rheumatoid arthritis are at higher risk because these illnesses can interfere with red blood cell production or cause chronic blood loss.^[2][4]

It is advisable to see a healthcare provider if you notice symptoms like dizziness, headaches, pale or yellowish skin, cold hands and feet, or an irregular or fast heartbeat. These signs suggest your body is struggling to deliver oxygen to vital organs. You should also seek medical attention if you experience chest pain, as severe anaemia can strain the heart. If you have been told during a blood donation that your hemoglobin levels are low, this is another important signal to follow up with a doctor for proper testing.^[1][2]

Older adults should also be vigilant about anaemia symptoms. As people age, the risk of developing anaemia increases due to higher likelihood of chronic diseases, medication use, and changes in dietary habits. Additionally, anyone who has undergone gastric bypass surgery or has digestive conditions like Crohn’s disease may have difficulty absorbing iron and other nutrients, making regular monitoring important.^[4][17]

Even if you do not have obvious symptoms, regular health checkups that include blood testing can catch anaemia early. Many people do not realize they have anaemia until it shows up in routine blood work ordered for another reason. Early detection allows for treatment before the condition progresses to cause more serious complications.^[4]

Diagnostic Methods: Identifying Anaemia and Its Type

The diagnosis of anaemia begins with a conversation between you and your healthcare provider. Your doctor will ask about your medical history, including any chronic illnesses you may have, medications you take, your dietary habits, and whether you have a family history of blood disorders. Women will be asked about their menstrual periods, particularly if they are heavy or prolonged. This information helps the doctor understand potential causes and risk factors for anaemia in your specific situation.^[11]

A physical examination follows the medical history discussion. Your doctor will look for signs of anaemia such as pale or yellowish skin, rapid or irregular heartbeat, and general weakness. They may listen to your heart and lungs, check your abdomen for enlargement of organs like the spleen or liver, and examine your hands and feet for coldness or unusual appearance. These physical findings, combined with your reported symptoms, help guide which tests should be ordered.^[11]

The most important diagnostic test for anaemia is called a complete blood count, often shortened to CBC. This is a simple blood test where a sample of your blood is drawn from a vein, usually in your arm, and sent to a laboratory for analysis. The CBC measures several key components of your blood. It counts the number of red blood cells you have and measures the amount of hemoglobin, which is the iron-rich protein inside red blood cells that carries oxygen throughout your body.^[11][2]

In men, anaemia is diagnosed when hemoglobin drops below 13.5 grams per deciliter. For women, the threshold is 12.0 grams per deciliter. In children, normal values vary depending on age. The CBC also measures hematocrit, which is the percentage of your blood volume made up of red blood cells. For men, typical hematocrit values range between 40% and 52%, while for women the range is generally between 35% and 47%.^[4][11]

Beyond just counting cells and measuring hemoglobin, the CBC provides information about the size and shape of your red blood cells. This is critically important because different types of anaemia produce different-looking red blood cells. Doctors examine the mean corpuscular volume, or MCV, which tells them whether your red blood cells are smaller than normal (microcytic), normal-sized (normocytic), or larger than normal (macrocytic). This classification helps narrow down the cause of anaemia.^[8][13]

If your red blood cells are small and pale, this often points to iron deficiency anaemia or thalassemia. Large red blood cells may indicate vitamin B12 or folate deficiency. Normal-sized cells that are simply too few in number can occur with kidney disease, chronic diseases causing inflammation, or bone marrow problems. By looking at these characteristics, your doctor can determine which type of anaemia you have and what additional tests might be needed.^[8][13]

Additional blood tests help identify the specific cause of anaemia. An iron test measures how much iron is stored in your body and how much is circulating in your blood. A ferritin blood test checks your body’s iron stores. Low ferritin levels confirm iron deficiency. Tests for vitamin B12 and folate levels can identify vitamin deficiency anaemia. A reticulocyte count measures how many young, newly made red blood cells are in your blood, which tells doctors whether your bone marrow is producing red blood cells properly.^[9][11]

If your doctor suspects your red blood cells are being destroyed too quickly, they may order tests to look for hemolytic anemia. These tests include measuring substances like bilirubin and lactate dehydrogenase, which increase when red blood cells break down. A blood smear test involves placing a drop of your blood on a glass slide and examining it under a microscope to look at the actual shape and appearance of individual red blood cells. This can reveal abnormalities like sickle-shaped cells or damaged cells.^[9]

In some cases, particularly when the cause of anaemia is unclear or when a serious bone marrow disorder is suspected, a bone marrow biopsy may be necessary. This procedure involves removing a small sample of bone marrow, usually from the hip bone, to examine how well your body is producing blood cells. While this sounds concerning, it is performed under local anesthesia to minimize discomfort. The bone marrow sample is analyzed in a laboratory to check for problems like aplastic anaemia, leukemia, or other bone marrow disorders.^[4][11]

For women with heavy menstrual bleeding, doctors may recommend additional examinations to find the source of blood loss. A pelvic ultrasound can identify problems like uterine fibroids. If digestive bleeding is suspected, tests like a fecal occult blood test check for hidden blood in stool samples. More invasive procedures like colonoscopy or endoscopy may be needed to directly visualize the stomach, intestines, or colon to find ulcers, polyps, or tumors that could be causing blood loss.^[9][11]

For inherited types of anaemia, genetic testing may be recommended. Conditions like sickle cell anaemia, thalassemia, and other hereditary blood disorders can be identified through specialized blood tests that analyze your hemoglobin structure or genetic makeup. If you have a family history of blood disorders, your doctor may order these tests even if your symptoms are mild. Early diagnosis of inherited anaemia helps with family planning decisions and long-term management strategies.^[2][8]

Diagnostics for Clinical Trial Qualification

When patients with anaemia are being considered for participation in clinical trials, the diagnostic process becomes more standardized and detailed. Clinical trials are research studies that test new treatments or approaches to managing anaemia. To ensure the safety of participants and the accuracy of study results, researchers need to confirm that everyone enrolled meets specific criteria based on their type and severity of anaemia.^[12]

The foundation of clinical trial screening is the complete blood count test. However, for trial purposes, the hemoglobin measurement must meet very specific thresholds that are defined in the study protocol. For example, a trial testing a treatment for moderate anaemia might only accept participants whose hemoglobin falls between certain values, perhaps 8 to 10 grams per deciliter. This ensures that all participants have a similar degree of anaemia at the start of the study.^[12]

Beyond basic blood counts, clinical trial qualification often requires tests to confirm the exact type of anaemia. For iron deficiency anaemia trials, participants typically need to have documented low iron stores through ferritin testing and other iron studies. The trial may specify that ferritin levels must be below a certain number to confirm true iron deficiency rather than anaemia from another cause. Similarly, trials focusing on vitamin B12 deficiency anaemia require blood tests showing low B12 levels before enrollment.^[11][12]

Reticulocyte counts are particularly important in clinical trial screening. This test measures how actively your bone marrow is trying to produce new red blood cells. A low reticulocyte count suggests your bone marrow is not responding properly, which might indicate aplastic anaemia or bone marrow failure. A high reticulocyte count suggests your bone marrow is working hard to replace red blood cells that are being lost or destroyed, which occurs in hemolytic anaemia or after acute bleeding. Clinical trials studying specific types of anaemia use reticulocyte counts to ensure participants have the correct underlying problem.^[13]

For trials studying inherited blood disorders like thalassemia or sickle cell disease, genetic testing and specialized hemoglobin analysis are mandatory. A hemoglobin electrophoresis test separates and identifies different types of hemoglobin in your blood. This test can confirm the presence of abnormal hemoglobin types that define conditions like sickle cell anaemia. Genetic testing may be required to identify specific mutations responsible for the disorder, especially in trials testing gene therapy or other targeted treatments.^[9][16]

Clinical trials may also require more extensive testing to rule out other conditions that could interfere with the study. Blood tests checking kidney function, liver function, and thyroid function are common. These help researchers ensure that anaemia is not secondary to another serious disease that might affect how well the experimental treatment works or that might make the treatment unsafe. Imaging studies like ultrasounds or CT scans might be needed if the trial focuses on anaemia caused by internal bleeding or organ problems.^[11]

Bone marrow examination is frequently required for clinical trials studying severe forms of anaemia, particularly aplastic anaemia or myelodysplastic syndromes. A bone marrow biopsy and aspiration provide detailed information about how many blood-forming cells are present and whether they are functioning normally. This invasive procedure is justified in clinical trials because researchers need to be absolutely certain about the diagnosis and severity before testing potentially powerful but unproven treatments.^[4][16]

Repeat blood testing is a standard part of clinical trial participation. Baseline tests are performed before any treatment begins to establish your starting point. Then, blood is drawn at regular intervals throughout the study to monitor how your anaemia responds to the experimental treatment. These serial measurements allow researchers to track changes in hemoglobin levels, red blood cell counts, and other markers over time. The frequency of testing varies by study but may be as often as weekly in early-phase trials.^[12]

Some clinical trials studying new treatments for anaemia, particularly those testing medications that stimulate red blood cell production, require specialized testing of erythropoietin levels. Erythropoietin is a hormone made by the kidneys that signals the bone marrow to produce more red blood cells. Measuring this hormone helps researchers understand whether anaemia is due to insufficient erythropoietin production, which occurs in kidney disease, or whether the bone marrow is not responding to normal erythropoietin signals.^[13]

Safety monitoring in clinical trials includes watching for complications related to anaemia or its treatment. Regular assessments of vital signs, including blood pressure and heart rate, help identify whether severe anaemia is straining the cardiovascular system. Electrocardiograms may be performed to check heart function. Blood tests monitoring for infection risk become important in trials studying treatments that might affect the immune system or white blood cell production alongside red blood cells.^[12]

Quality of life assessments, while not strictly diagnostic tests, are increasingly included in clinical trial protocols. Participants may be asked to complete questionnaires about their energy levels, ability to perform daily activities, and overall well-being. These assessments help researchers understand not just whether a treatment improves blood test results, but whether it makes patients feel better in their day-to-day lives. This patient-centered approach recognizes that the ultimate goal of anaemia treatment is to improve how people feel and function, not just to change laboratory values.^[12]